BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36719696)

  • 1. SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.
    Tripathi SH; Corr A; Kumar A; Ungerer H; Salmon M; Adappa ND; Bosso JV
    Allergy Asthma Proc; 2023 Jan; 44(1):78-80. PubMed ID: 36719696
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
    Sweis AM; Locke TB; Ig-Izevbekhai KI; Lin TC; Kumar A; Douglas JE; Corr AM; Civantos AM; Tripathi SH; Kennedy DW; Kohanski MA; Palmer JN; Adappa ND; Bosso JV
    Allergy Asthma Proc; 2021 Mar; 42(2):136-141. PubMed ID: 33685558
    [No Abstract]   [Full Text] [Related]  

  • 3. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcomes in aspirin-exacerbated respiratory disease without aspirin desensitization.
    Grose E; Lee DJ; Yip J; Cottrell J; Sykes J; Lee JK; Lee JM
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1149-1157. PubMed ID: 32558318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
    Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
    HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.
    Adappa ND; Ranasinghe VJ; Trope M; Brooks SG; Glicksman JT; Parasher AK; Palmer JN; Bosso JV
    Int Forum Allergy Rhinol; 2018 Jan; 8(1):49-53. PubMed ID: 29105347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-intervention SNOT-22 scores predict outcomes in aspirin exacerbated respiratory disease.
    Kuan EC; Kennedy WP; Patel NN; Goshtasbi K; Kohanski MA; Tong CCL; Papagiannopoulos P; Kennedy DW; Palmer JN; Adappa ND; Bosso JV
    Am J Otolaryngol; 2021; 42(5):103025. PubMed ID: 33836482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
    Mullur J; Buchheit KM
    Ann Allergy Asthma Immunol; 2023 Sep; 131(3):317-324. PubMed ID: 37225000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Rhinosinusitis Outcomes of Patients With Aspirin-Exacerbated Respiratory Disease Treated With Budesonide Irrigations: A Case Series.
    Talat R; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Ann Otol Rhinol Laryngol; 2022 Oct; 131(10):1130-1136. PubMed ID: 34775833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK; Jerschow E; Divekar RD
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis.
    Morrissey DK; Bassiouni A; Psaltis AJ; Naidoo Y; Wormald PJ
    Int Forum Allergy Rhinol; 2016 Aug; 6(8):820-5. PubMed ID: 26992029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major complications of aspirin desensitization and maintenance therapy in aspirin-exacerbated respiratory disease.
    Sweis AM; Locke TB; Ig-Izevbekhai KI; Lin TC; Gleeson PK; Civantos AM; Kumar A; Corr AM; Kohanski MA; Palmer JN; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2021 Feb; 11(2):115-119. PubMed ID: 32671928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey.
    Locke TB; Sweis AM; Douglas JE; Ig-Izevbekhai KI; Stevens EM; Civantos AM; McCarty EB; Kumar A; Kohanski MA; Kennedy DW; Palmer JN; Bosso JV; Adappa ND
    Am J Rhinol Allergy; 2021 Nov; 35(6):790-797. PubMed ID: 33691498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.
    D'Souza GE; Nwagu U; Barton B; Unsal AA; Rabinowitz MR; Rosen MR; Nyquist GG; Cohn J; Most J; Toskala EM
    Int Forum Allergy Rhinol; 2022 Mar; 12(3):306-309. PubMed ID: 34719120
    [No Abstract]   [Full Text] [Related]  

  • 17. AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study.
    San Nicoló M; Habermann N; Havel M
    Int Arch Allergy Immunol; 2020; 181(10):790-798. PubMed ID: 32777782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not just snot: Local inflammatory profiles in patients with aspirin-exacerbated respiratory disease differ from patients with aspirin-tolerant chronic rhinosinusitis.
    Chiang S; Yu SE; Athni TS; Bergmark RW; Maxfield AZ; Roditi RE; Buchheit KM; Lundberg M; Mitchell MB; Lee SE
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):110-113. PubMed ID: 37325975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Aspirin-Exacerbated Respiratory Disease and Atherosclerotic Cardiovascular Disease: A Retrospective Review of US Claims Data.
    Adame MJ; Raji M; Shan Y; Zhang Y; Kuo YF; Tripple JW
    J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3445-3453.e6. PubMed ID: 37468040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.